Topical combination of diclofenac, calcipotriol, and difluoromethylornithine has beneficial effects comparable to 5-fluorouracil for the treatment of non-melanoma skin cancer in mice

Topical Treatment with Diclofenac, Calcipotriol (Vitamin-D3 Analog) and Difluoromethylornithine (DFMO) Does Not Prevent Nonmelanoma Skin Cancer in Mice

(2013) H. C. Pommergaard et al.   CANCER INVESTIGATION

Effects of magnolol on UVB-induced skin cancer development in mice and its possible mechanism of action

(2011) Chandeshwari Chilampalli et al.   BMC CANCER

High death rate in mice treated topically with diclofenac

(2011) Catharina M. Lerche et al.   EXPERIMENTAL DERMATOLOGY

Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer

(2011) Gery P. Guy et al.   PHARMACOECONOMICS

Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006

(2010) Howard W. Rogers et al.   ARCHIVES OF DERMATOLOGY

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of  -Difluoromethylornithine in Subjects with Previous History of Skin Cancer

(2010) H. H. Bailey et al.   Cancer Prevention Research

Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial

(2010) Craig A. Elmets et al.   JNCI-Journal of the National Cancer Institute

Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men

(2009) Jean Y. Tang et al.   CANCER CAUSES & CONTROL

Nonsteroidal Anti-Inflammatory Drugs and Lower Gastrointestinal Complications

(2009) Angel Lanas et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Vitamin D and skin cancer: A meta-analysis

(2008) Sara Gandini et al.   EUROPEAN JOURNAL OF CANCER